RSS Feeds
Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
- Aine M. Kelly, MD, MS;
- Ben Dwamena, MD;
- Paul Cronin, MD, MS;
- Steven J. Bernstein, MD, MPH; and
- Ruth C. Carlos, MD, MS
- From the University of Michigan and Veteran Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
-
Figure 1. Trial identification, inclusion, and exclusion. -
Figure 2. Forest plot describing relative risk for contrast-induced nephropathy, by treatment agent.The intervention and control columns show the number of events among the total number of participants randomly assigned to the group for each study. We estimated heterogeneity within subgroups by using the I2 statistic.
Related Clinical Content
